Prevenar (Pneumococcal polysaccharide conjugate vaccine): Reviews and patient testimonials
Back to the list of medications
Medication indications
Prevenar 13 suspension for injection
Active immunisation for the prevention of invasive disease, pneumonia and acute otitis media caused by Streptococcus pneumoniae in infants, children and adolescents from 6 weeks to 17 years of age.
Active immunisation for the prevention of invasive disease and pneumonia caused by Streptococcus pneumoniae in adults ≥18 years of age and the elderly.
See sections 4.4 and 5.1 for information on protection against specific pneumococcal serotypes.
The use of Prevenar 13 should be determined on the basis of official recommendations taking into consideration the risk of invasive disease and pneumonia in different age groups, underlying comorbidities as well as the variability of serotype epidemiology in different geographical areas.
Route of administration: Injectable
Molecule: Pneumococcal polysaccharide conjugate vaccine
Tips and advice of the community
Join Carenity and be the first to give your opinion on this medication.